Tandem Diabetes Care, Inc. TNDM

Company Overview

Tandem Diabetes Care, Inc. is a publicly traded medical device company focused on the design, development, and commercialization of insulin delivery systems for people with diabetes. The company operates within the diabetes technology and medical devices industries, with a primary emphasis on insulin pump therapy and integrated diabetes management solutions. Tandem’s core revenue drivers include sales of its insulin pump hardware, related disposable supplies, and software-enabled diabetes management technologies. Its flagship products include the t:slim X2 insulin pump, the Mobi insulin delivery system, and associated infusion sets and cartridges. The company also generates recurring revenue through consumables and ongoing patient support services.

Tandem primarily serves individuals with type 1 diabetes and insulin-dependent type 2 diabetes, along with healthcare providers and diabetes clinics. A key aspect of its market positioning is its integration with continuous glucose monitoring (CGM) systems and automated insulin delivery algorithms, particularly through partnerships with CGM manufacturers. The company was founded in 2006 and is headquartered in San Diego, California. Tandem evolved from an early-stage insulin pump developer into a major participant in the automated insulin delivery market following FDA clearances for advanced hybrid closed-loop technologies and software update capabilities that allow remote feature upgrades without replacing hardware.